Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19

L. Bowles, S. Platton, Nada Yartey, Minal Dave, Kurtis Lee, D. Hart, Vickie MacDonald, Laura Green, S. Sivapalaratnam, K. Pasi, P. Maccallum

The New England journal of medicine, 2020

Prolonged aPTT in Patients with Covid-19 In this study, 20% of patients with Covid-19 had a prolonged activated partial-thromboplastin time. In 90% of these cases, the cause was lupus anticoagulant...

Cited by 149 publications.

Field of study: Medicine

10.1056/NEJMc2013656